UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Seminars in oncology, ISSN 0093-7754, 06/2018, Volume 45, Issue 3, pp. 105 - 106
Journal Article
Seminars in oncology, ISSN 0093-7754, 04/2017, Volume 44, Issue 2, pp. 113 - 113
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. e81 - e86
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Signal Transduction | Humans | Neoplasms - radiotherapy | Neoplasms - diagnosis | Molecular Targeted Therapy | Neoplasms - drug therapy | Precision Medicine | Medical ethics | Medicine, Preventive | Preventive health services | Index Medicus
Journal Article
Seminars in oncology, ISSN 0093-7754, 12/2017, Volume 44, Issue 6, pp. 395 - 403
CDK 6 | Abemaciclib | CDK 6 inhibitors | retinoblastoma protein | me-too cancer therapies | retinoblastoma | CDK4/6 inhibitors | Palbociclib | Ribociclib | FDA approvals | CDK 4 | CDK 4 inhibitors | Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Aminopyridines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Humans | Piperazines - therapeutic use | Purines - therapeutic use | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Molecular Targeted Therapy | Breast Neoplasms - drug therapy | Benzimidazoles - therapeutic use | Pyridines - therapeutic use
Journal Article
JAMA otolaryngology-- head & neck surgery, ISSN 2168-6181, 07/2014, Volume 140, Issue 12, pp. 1225 - 1236
Otorhinolaryngology | Life Sciences & Biomedicine | Surgery | Science & Technology | Medical Oncology | Health Care Costs | United States | Humans | Head and Neck Neoplasms - therapy | Diffusion of Innovation | Therapies, Investigational | Unnecessary Procedures | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 06/2011, Volume 117, Issue 22, pp. 5827 - 5834
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Lymphoma, T-Cell, Peripheral - drug therapy | Skin Neoplasms - drug therapy | Humans | Middle Aged | Depsipeptides - pharmacokinetics | Male | Survival Rate | Treatment Outcome | Lymphoma, T-Cell, Cutaneous - drug therapy | Remission Induction | Disease Progression | Tissue Distribution | Antibiotics, Antineoplastic - therapeutic use | Lymphoma, Large-Cell, Anaplastic - drug therapy | Aged, 80 and over | Adult | Female | Aged | Depsipeptides - therapeutic use | Antibiotics, Antineoplastic - pharmacokinetics | Index Medicus | Abridged Index Medicus | Lymphoid Neoplasia | Clinical Trials and Observations
Journal Article
Seminars in oncology, ISSN 0093-7754, 02/2019, Volume 46, Issue 1, pp. 1 - 2
Journal Article
The oncologist (Dayton, Ohio), ISSN 1083-7159, 09/2016, Volume 21, Issue 9, pp. 1033 - 1034
Journal Article
Nature reviews. Clinical oncology, ISSN 1759-4774, 03/2018, Volume 15, Issue 3, pp. 183 - 192
Life Sciences & Biomedicine | Oncology | Science & Technology | Care and treatment | Oncology, Experimental | Innovations | Genetic research | Genetic aspects | Research | Health aspects | Oncogenes | Cancer | Precision medicine | Biopsy | Decision making | Clinical trials | Cytotoxicity | Genomes | Cytotoxic agents | Tumors | Index Medicus
Journal Article
Nature reviews. Cancer, ISSN 1474-175X, 04/2005, Volume 5, Issue 4, pp. 275 - 284
Life Sciences & Biomedicine | Oncology | Science & Technology | Signal Transduction | Humans | Pluripotent Stem Cells - physiology | Drug Resistance, Neoplasm | ATP-Binding Cassette Transporters - physiology | Trans-Activators - physiology | Hedgehog Proteins | Cell Lineage | Animals | Models, Animal | Antineoplastic Agents - pharmacology | Mice | Neoplastic Stem Cells - physiology | Care and treatment | Stem cells | Physiological aspects | Genetic aspects | Research | Drug resistance | Risk factors | Tumors | Index Medicus
Journal Article
11.
Long-acting somatostatin analogues in the treatment of unresectable/metastatic neuroendocrine tumors
Seminars in oncology, ISSN 0093-7754, 04/2017, Volume 44, Issue 2, pp. 141 - 156
SSTR | Octreotide | Somatostatin receptor | Neuroendocrine tumor | Lanreotide | Sandostatin LAR | Life Sciences & Biomedicine | Oncology | Science & Technology | Neuroendocrine Tumors - pathology | Somatostatin - analogs & derivatives | Humans | Somatostatin - administration & dosage | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Octreotide - therapeutic use | Peptides, Cyclic - administration & dosage | Neuroendocrine Tumors - drug therapy | Peptides, Cyclic - therapeutic use | Octreotide - administration & dosage | Somatostatin - therapeutic use | Delayed-Action Preparations
Journal Article
Drug resistance updates, ISSN 1368-7646, 2007, Volume 10, Issue 1, pp. 59 - 67
Infectious Disease | Hematology, Oncology and Palliative Medicine | Translocation | Amplification | Mutations | Imatinib | Erlotinib | MicroRNAs | Epigenetics | CpG | Drug resistance | Gefitinib | Rearrangements | p53 | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Promoter Regions, Genetic | Translocation, Genetic | Epigenesis, Genetic | Humans | Antineoplastic Agents - therapeutic use | Mutation - genetics | Neoplasms - drug therapy | Drug Resistance, Neoplasm - genetics | Phenotype | Gene Amplification | Neoplasms - genetics | Gene Rearrangement | Antineoplastic Agents - pharmacology | Gene mutations | Genetic research | Index Medicus
Journal Article